Menu
The company attended the Superbones/Superwounds West Conference this year at the M Resort in Las Vegas. Many of the attendees focused on diabetic foot care stopped by the booth to see the ETF in action. Incidentally, the company was delighted to learn that one of the speakers referenced the product during a lecture on wound care. Many thanks to Debbie Green, RN for including our product in her presentation.
Dr. O’Brien traveled to beautiful Niagara Falls, Ontario to attend the 2016 Annual CAWC meeting. In addition to introducing attendees to the ETF in the exhibit hall, Dr. O’Brien’s research was selected for presentation as an oral abstract. He delivered a brief talk on the proof-of-concept study that validated the ETF’s ability to detect neuropathy compared to conventional standards.
A recent article in Podiatry Today magazine cited the use of the ETF when testing the status of vibratory sensation. In the article entitled, “Managing Neuropathy And Pain In Wound Care Patients” Dr. Cythinia Cernak notes using the ETF for diagnosing and assessing neuropathy in her patients.
